NL128902C - - Google Patents

Info

Publication number: NL128902C
Authority: NL; Netherlands

Application number

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1960-06-06

Publication of NL128902C publication Critical patent/NL128902C/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NL128902D 1960-06-06 NL128902C (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33896A US3074852A (en)	1960-06-06	1960-06-06	Pharmaceuticals with delayed release

Publications (1)

Publication Number	Publication Date
NL128902C true NL128902C (hu)

Family

ID=21873090

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NL265428D NL265428A (hu)	1960-06-06
NL128902D NL128902C (hu)	1960-06-06

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NL265428D NL265428A (hu)	1960-06-06

Country Status (9)

Country	Link
US (1)	US3074852A (hu)
BE (1)	BE604564A (hu)
DE (1)	DE1279896C2 (hu)
ES (1)	ES267532A1 (hu)
FI (1)	FI40562B (hu)
FR (1)	FR1409M (hu)
GB (1)	GB905000A (hu)
NL (2)	NL128902C (hu)
SE (1)	SE328372B (hu)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE636865A (hu) *	1962-08-31
US3330729A (en) *	1963-10-04	1967-07-11	Goodrich Co B F	Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent
CH415963A (de) *	1964-09-04	1966-06-30	Wander Ag Dr A	Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3499960A (en) *	1965-01-25	1970-03-10	Merck & Co Inc	Palatable coated particles of an anion exchange resin
US3619200A (en) *	1966-06-21	1971-11-09	Commw Scient Ind Res Org	Method and food composition for feeding ruminants
US3458622A (en) *	1967-04-07	1969-07-29	Squibb & Sons Inc	Controlled release tablet
IE32806B1 (en) *	1968-05-21	1973-12-12	American Home Prod	Sustained release drug composition
US4248857A (en) *	1979-08-09	1981-02-03	American Home Products Corporation	Sustained release pharmaceutical compositions
US4309404A (en) *	1979-08-09	1982-01-05	American Home Products Corporation	Sustained release pharmaceutical compositions
NZ195933A (en) *	1980-01-11	1982-11-23	Boots Co Ltd	Sustained-release pharmaceutical compositions in tablet form
US4308251A (en) *	1980-01-11	1981-12-29	Boots Pharmaceuticals, Inc.	Controlled release formulations of orally-active medicaments
CH666406A5 (de) *	1984-02-29	1988-07-29	Sandoz Ag	Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
US4666705A (en) *	1985-06-03	1987-05-19	E. R. Squibb & Sons, Inc.	Controlled release formulation
US4904476A (en) *	1986-03-04	1990-02-27	American Home Products Corporation	Formulations providing three distinct releases
US4794001A (en) *	1986-03-04	1988-12-27	American Home Products Corporation	Formulations providing three distinct releases
US4994276A (en) *	1988-09-19	1991-02-19	Edward Mendell Co., Inc.	Directly compressible sustained release excipient
CH672922A5 (hu) *	1987-09-25	1990-01-15	Battelle Memorial Institute
US5128143A (en) *	1988-09-19	1992-07-07	Edward Mendell Co., Inc.	Sustained release excipient and tablet formulation
US5169639A (en) *	1988-09-19	1992-12-08	Edward Mendell Co., Inc.	Controlled release verapamil tablets
US5135757A (en) *	1988-09-19	1992-08-04	Edward Mendell Co., Inc.	Compressible sustained release solid dosage forms
JPH02212416A (ja) *	1988-12-22	1990-08-23	Monsanto Co	薬物用の膨潤制御経口送達システム
ATE113841T1 (de)	1989-10-31	1994-11-15	Columbia Lab Inc	Mittel zur feuchthaltung vaginalen gewebes.
US5250293A (en) *	1991-04-22	1993-10-05	Gleich Gerald J	Method for the treatment of hypersensitivity diseases by administration of anionic polymers
US5498410A (en) *	1991-04-22	1996-03-12	Gleich; Gerald J.	Method for the treatment of eosinophil-associated conditions with anionic polymers
US5681555A (en) *	1991-04-22	1997-10-28	Gleich; Gerald J.	Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
US5407686A (en) *	1991-11-27	1995-04-18	Sidmak Laboratories, Inc.	Sustained release composition for oral administration of active ingredient
US5472711A (en) *	1992-07-30	1995-12-05	Edward Mendell Co., Inc.	Agglomerated hydrophilic complexes with multi-phasic release characteristics
US6440457B1 (en) *	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
US5667492A (en) *	1994-10-07	1997-09-16	Columbia Laboratories, Inc.	Use and composition of an anti-sexually transmitted diseases formulation
US6245351B1 (en) *	1996-03-07	2001-06-12	Takeda Chemical Industries, Ltd.	Controlled-release composition
US6596777B1 (en)	1997-05-29	2003-07-22	Mcneil-Ppc, Inc.	Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6919373B1 (en) *	1996-11-12	2005-07-19	Alza Corporation	Methods and devices for providing prolonged drug therapy
US20010006644A1 (en) *	1997-07-31	2001-07-05	David J. Bova	Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
IN186245B (hu)	1997-09-19	2001-07-14	Ranbaxy Lab Ltd
AU2141202A (en) *	2000-12-05	2002-06-18	Alexander Macgregor	Hydrostatic delivery system for controlled delivery of agent
PE20040134A1 (es) *	2002-07-25	2004-03-06	Pharmacia Corp	Forma de dosificacion de una vez al dia de pramipexol
WO2005030178A1 (en) *	2003-09-30	2005-04-07	Lupin Ltd.	Extended release formulation of beta-lactam antibiotics
UA93608C2 (ru) *	2004-08-13	2011-02-25	Берингер Ингельхайм Интернациональ Гмбх	композициЯ таблетки пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, СПОСОБ EE ИЗГОТОВЛЕНИЯ И EE ПРИМЕНЕНИЕ
WO2006015943A2 (en) *	2004-08-13	2006-02-16	Boehringer Ingelheim International Gmbh	Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
CN101229378A (zh) *	2005-05-05	2008-07-30	国家淀粉及化学投资控股公司	用于送递活性剂的组合物
US20090098202A1 (en) *	2006-02-10	2009-04-16	Boehringer Ingelheim International Gmbh	Extended Release Formulation
US20090041844A1 (en) *	2006-02-10	2009-02-12	Boehringer Ingelheim International Gmbh	Modified Release Formulation
US7538652B2 (en) *	2006-08-29	2009-05-26	International Business Machines Corporation	Electrical component tuned by conductive layer deletion

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE631201C (de) *	1932-08-07	1936-06-16	Chemische Forschungs Gmbh	Traegerstoff fuer Arzneimittel
DE644759C (de) *	1932-11-23	1937-05-12	I G Farbenindustrie Akt Ges	Verfahren zum UEberziehen von Arzneiformen mit gegen Magensaeure und Magenfermente bestaendigen UEberzuegen
CH283585A (de) *	1950-03-15	1952-06-15	Hoffmann La Roche	Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US2798053A (en) *	1952-09-03	1957-07-02	Goodrich Co B F	Carboxylic polymers
BE575343A (hu) *	1955-09-09
US2912358A (en) *	1955-11-02	1959-11-10	Bristol Myers Co	Antacid preparations containing acrylic acid polymers and magnesium antacids
US2909462A (en) *	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
US2854381A (en) *	1955-12-08	1958-09-30	Bristol Myers Co	Resin laxative tablets containing hydrolyzed keratin
US2887436A (en) *	1956-05-28	1959-05-19	Pfizer & Co C	Pharmaceutical compositions
US2887437A (en) *	1956-08-22	1959-05-19	Pfizer & Co C	Palatable vitamin tablet containing an amino acid
US2887439A (en) *	1956-09-28	1959-05-19	Pfizer & Co C	Palatable antihistamine tablet
DE1070381B (de) *	1957-03-15	1959-12-03	Rohm & LIaas Company, Philadelphia, Pa. (V. St. A.)	Verfahren zur Herstellung von Ionenaustauscherharzen auf Basis der Acrylsäuren und Methacrylsäuren
NL230864A (hu) *	1957-08-27
US2918411A (en) *	1957-11-01	1959-12-22	Olin Mathieson	Pharmaceutical preparations
NL109170C (hu) *	1958-02-03
US2957804A (en) *	1958-06-06	1960-10-25	Harlan R Shuyler	Pesticide
US2987445A (en) *	1958-10-10	1961-06-06	Rohm & Haas	Drug composition
US3033754A (en) *	1959-12-21	1962-05-08	Lakeside Lab Inc	Tablets containing hydrazine derivatives

0
- NL NL265428D patent/NL265428A/xx unknown
- NL NL128902D patent/NL128902C/xx active
- BE BE604564D patent/BE604564A/xx unknown
1960
- 1960-06-06 US US33896A patent/US3074852A/en not_active Expired - Lifetime
1961
- 1961-05-20 ES ES0267532A patent/ES267532A1/es not_active Expired
- 1961-05-23 GB GB18505/61A patent/GB905000A/en not_active Expired
- 1961-05-24 DE DE1961A0037521 patent/DE1279896C2/de not_active Expired
- 1961-05-29 FI FI1033/61A patent/FI40562B/fi active
- 1961-05-31 SE SE05710/61A patent/SE328372B/xx unknown
- 1961-06-06 FR FR864028A patent/FR1409M/fr active Active

Also Published As

Publication number	Publication date
DE1279896B (de)	1968-10-10
FI40562B (hu)	1968-11-30
ES267532A1 (es)	1961-11-16
US3074852A (en)	1963-01-22
SE328372B (hu)	1970-09-14
GB905000A (en)	1962-09-05
NL265428A (hu)
FR1409M (fr)	1962-07-23
BE604564A (hu)
DE1279896C2 (de)	1974-03-14

Publication	Publication Date	Title
FI40562B (hu)	1968-11-30
FI40832B (hu)	1969-02-28
DE1494127B2 (hu)	1970-05-27
FR781M (hu)	1961-09-04
DE1423866B2 (hu)	1969-11-06
FR1228553A (hu)	1960-08-31
BE606732A (hu)
BE601358A (hu)
BE603978A (hu)
BE603213A (hu)
BE603033A (hu)
BE604263A (hu)
BE602014A (hu)
BE604625A (hu)
BE604657A (hu)
BE602010A (hu)
BE604885A (hu)
BE601903A (hu)
BE601692A (hu)
CH296960A4 (hu)	1964-04-30
CH1489561A4 (hu)	1963-11-30
BE734292A (hu)	1969-11-17
BE480697A (hu)
BE605517A (hu)
BE601598A (hu)	1961-09-21